SRSF1 and hepatocellular carcinoma: To confirm SRSF1’s glycolytic function in HCC tissues, PET/CT imaging of 40 patients revealed significantly higher SUVmax values in the high SRSF1 group compared to the low SRSF1 group (Supplementary Fig. 4f).